Drug Regulation in the Era of Individualized Therapies

N Engl J Med. 2019 Oct 24;381(17):1678-1680. doi: 10.1056/NEJMe1911295. Epub 2019 Oct 9.

Authors

Janet Woodcock¹, Peter Marks¹

Affiliation

¹ From the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD.

PMID: 31597016
DOI: 10.1056/NEJMe1911295

No abstract available

Publication types

Editorial
Comment

MeSH terms

Drug and Narcotic Control*
Humans
Oligonucleotides
Precision Medicine*
Rare Diseases

Substances

Oligonucleotides